These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 11054291)

  • 21. Transthyretin forms amyloid fibrils at physiological pH with ultrasonication.
    Misumi Y; Ueda M; Fujimori H; Shinriki S; Meng W; Kim J; Saito S; Obayashi K; Uchino M; Ando Y
    Amyloid; 2008 Dec; 15(4):234-9. PubMed ID: 19065294
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molten globule structure of equine beta-lactoglobulin probed by hydrogen exchange.
    Kobayashi T; Ikeguchi M; Sugai S
    J Mol Biol; 2000 Jun; 299(3):757-70. PubMed ID: 10835282
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transthyretin fibrillogenesis entails the assembly of monomers: a molecular model for in vitro assembled transthyretin amyloid-like fibrils.
    Cardoso I; Goldsbury CS; Müller SA; Olivieri V; Wirtz S; Damas AM; Aebi U; Saraiva MJ
    J Mol Biol; 2002 Apr; 317(5):683-95. PubMed ID: 11955017
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cys-10 mixed disulfide modifications exacerbate transthyretin familial variant amyloidogenicity: a likely explanation for variable clinical expression of amyloidosis and the lack of pathology in C10S/V30M transgenic mice?
    Zhang Q; Kelly JW
    Biochemistry; 2005 Jun; 44(25):9079-85. PubMed ID: 15966731
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The binding of 2,4-dinitrophenol to wild-type and amyloidogenic transthyretin.
    Morais-de-Sá E; Neto-Silva RM; Pereira PJ; Saraiva MJ; Damas AM
    Acta Crystallogr D Biol Crystallogr; 2006 May; 62(Pt 5):512-9. PubMed ID: 16627944
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Kinetic stabilization of an oligomeric protein by a single ligand binding event.
    Wiseman RL; Johnson SM; Kelker MS; Foss T; Wilson IA; Kelly JW
    J Am Chem Soc; 2005 Apr; 127(15):5540-51. PubMed ID: 15826192
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acidic pH-induced conformational changes in amyloidogenic mutant transthyretin.
    Pasquato N; Berni R; Folli C; Alfieri B; Cendron L; Zanotti G
    J Mol Biol; 2007 Feb; 366(3):711-9. PubMed ID: 17196219
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cys10 mixed disulfides make transthyretin more amyloidogenic under mildly acidic conditions.
    Zhang Q; Kelly JW
    Biochemistry; 2003 Jul; 42(29):8756-61. PubMed ID: 12873136
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biophysical analyses of the transthyretin variants, Tyr114His and Tyr116Ser, associated with familial amyloidotic polyneuropathy.
    Shinohara Y; Mizuguchi M; Matsubara K; Takeuchi M; Matsuura A; Aoki T; Igarashi K; Nagadome H; Terada Y; Kawano K
    Biochemistry; 2003 Dec; 42(51):15053-60. PubMed ID: 14690414
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Native state kinetic stabilization as a strategy to ameliorate protein misfolding diseases: a focus on the transthyretin amyloidoses.
    Johnson SM; Wiseman RL; Sekijima Y; Green NS; Adamski-Werner SL; Kelly JW
    Acc Chem Res; 2005 Dec; 38(12):911-21. PubMed ID: 16359163
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diflunisal analogues stabilize the native state of transthyretin. Potent inhibition of amyloidogenesis.
    Adamski-Werner SL; Palaninathan SK; Sacchettini JC; Kelly JW
    J Med Chem; 2004 Jan; 47(2):355-74. PubMed ID: 14711308
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Orally administered diflunisal stabilizes transthyretin against dissociation required for amyloidogenesis.
    Sekijima Y; Dendle MA; Kelly JW
    Amyloid; 2006 Dec; 13(4):236-49. PubMed ID: 17107884
    [TBL] [Abstract][Full Text] [Related]  

  • 33. X-ray crystallographic studies of two transthyretin variants: further insights into amyloidogenesis.
    Neto-Silva RM; Macedo-Ribeiro S; Pereira PJ; Coll M; Saraiva MJ; Damas AM
    Acta Crystallogr D Biol Crystallogr; 2005 Mar; 61(Pt 3):333-9. PubMed ID: 15735344
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transthyretin aggregation under partially denaturing conditions is a downhill polymerization.
    Hurshman AR; White JT; Powers ET; Kelly JW
    Biochemistry; 2004 Jun; 43(23):7365-81. PubMed ID: 15182180
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Different disease-causing mutations in transthyretin trigger the same conformational conversion.
    Steward RE; Armen RS; Daggett V
    Protein Eng Des Sel; 2008 Mar; 21(3):187-95. PubMed ID: 18276611
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mapping the core of the beta(2)-microglobulin amyloid fibril by H/D exchange.
    Hoshino M; Katou H; Hagihara Y; Hasegawa K; Naiki H; Goto Y
    Nat Struct Biol; 2002 May; 9(5):332-6. PubMed ID: 11967567
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An engineered transthyretin monomer that is nonamyloidogenic, unless it is partially denatured.
    Jiang X; Smith CS; Petrassi HM; Hammarström P; White JT; Sacchettini JC; Kelly JW
    Biochemistry; 2001 Sep; 40(38):11442-52. PubMed ID: 11560492
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diflunisal stabilizes familial amyloid polyneuropathy-associated transthyretin variant tetramers in serum against dissociation required for amyloidogenesis.
    Tojo K; Sekijima Y; Kelly JW; Ikeda S
    Neurosci Res; 2006 Dec; 56(4):441-9. PubMed ID: 17028027
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Crystal structure of rat transthyretin at 2.5 A resolution: first report on a unique tetrameric structure.
    Wojtczak A
    Acta Biochim Pol; 1997; 44(3):505-17. PubMed ID: 9511961
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of transthyretin amyloid fibril formation by 2,4-dinitrophenol through tetramer stabilization.
    Raghu P; Reddy GB; Sivakumar B
    Arch Biochem Biophys; 2002 Apr; 400(1):43-7. PubMed ID: 11913969
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.